Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Medicare Part B
Pharma
PhRMA pushes back on CMS' Part B MFN model in court
As the Trump administration advances plans to bring its “most favored nation” drug pricing model to Medicare Part B, PhRMA is pushing back in court.
Fraiser Kansteiner
Oct 8, 2026 8:05am
Fierce Healthcare
CMS finalizes model that brings MFN pricing to Part B
Sep 30, 2026 5:30pm
Fierce Healthcare
CMMI proposes new models to lower drug prices in Parts B, D
Dec 22, 2025 12:00pm
IRA biosim policy plays 'small' role in savings so far: report
Aug 29, 2024 1:35pm